Based upon other studies where increased MRP2 may invoke resistance to cytotoxic drugs,46 it is reasonable to speculate that the elevated pCREB evident in mouse adenomas and CRC may also occur in human CRC and have a role in compromising the therapeutic impact of these drugs. This evidence concerns the gene ABCC2 and colorectal carcinoma.